Fast and Secure Delivery Worldwide Express & Expedited Shipping Service
USD $122.50
IndiaPazolit, containing the active ingredient Pazopanib, is an oral medication primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. It functions as a targeted therapy that inhibits multiple receptor tyrosine kinases, which play a crucial role in tumor growth and angiogenesis (the formation of new blood vessels that supply the tumor).
Pazopanib works by blocking the action of certain proteins that promote the growth of cancer cells. By inhibiting these proteins, Pazolit helps to slow down or stop the growth of tumors, making it an effective treatment option for patients with specific types of cancer.
Pazolit is indicated for:
The recommended dosage of Pazolit is determined by the healthcare provider based on the patient's specific condition and response to treatment. It is typically taken once daily, with or without food. It's essential to follow the prescribed regimen and attend regular follow-up appointments to monitor treatment effectiveness and manage potential side effects.
Common side effects associated with Pazolit may include:
Patients should report any severe or persistent side effects to their healthcare provider immediately.
Before starting Pazolit, patients should inform their doctor about any pre-existing conditions, including liver problems, heart conditions, or high blood pressure. Regular monitoring of liver function and blood pressure is recommended during treatment.
Pazolit (Pazopanib) is a vital medication for patients with advanced kidney cancer and soft tissue sarcoma, offering a targeted approach to cancer treatment. Always consult with a healthcare professional for personalized medical advice and to understand the potential benefits and risks associated with this therapy.
